title: Biofilm formation by Clostridium difficile.
abstract: Clostridium difficile infection (CDI) is a major healthcare-associated disease worldwide. Recurring infections and increasing antibiotic resistance have complicated treatment of CDI. While C. difficile spores are important for transmission and persistence of CDI, other factors such as gut colonization and formation of bacterial communities in the gut may also contribute to pathogenesis and persistence, but have not been well investigated. Recently, we reported that important clinical C. difficile strains are able to form composite biofilms in vitro. C. difficile biofilm formation is a complex process, modulated by several different factors, including cell surface components and regulators. We also reported that bacteria within biofilms are more resistant to high concentrations of vancomycin, the antibiotic of choice for treatment of CDI. Here we summarize our recent findings and discuss the implications of biofilm formation by this anaerobic gut pathogen in disease pathogenesis and treatment.
authors.affiliation: Novartis Vaccines and Diagnostics; Siena, Italy.
authors.forename: Tanja
authors.initials: T
authors.lastname: Dapa
authors.affiliation: Novartis Vaccines and Diagnostics; Siena, Italy.
authors.forename: Meera
authors.initials: M
authors.lastname: Unnikrishnan
mesh_terms: D018441:Biofilms / Q000254:growth & development*; D016360:Clostridioides difficile / Q000502:physiology*
keywords: Clostridium difficile; anaerobic pathogen; antibiotic resistance; biofilm formation; sporulation
references.citation: Infect Immun. 2011 Oct;79(10):3905-12
references.pmid: 21788390
references.citation: J Bacteriol. 2009 Dec;191(23):7296-305
references.pmid: 19783633
references.citation: J Med Microbiol. 2011 Aug;60(Pt 8):1155-1161
references.pmid: 21349990
references.citation: Nat Rev Microbiol. 2009 Jul;7(7):526-36
references.pmid: 19528959
references.citation: Mol Microbiol. 2003 Oct;50(1):101-4
references.pmid: 14507367
references.citation: J Biol Chem. 2009 Dec 11;284(50):34666-73
references.pmid: 19808679
references.citation: Nat Rev Microbiol. 2005 May;3(5):383-96
references.pmid: 15864263
references.citation: FEMS Microbiol Lett. 2004 Jan 15;230(1):13-8
references.pmid: 14734160
references.citation: Clin Microbiol Rev. 2005 Apr;18(2):247-63
references.pmid: 15831824
references.citation: Infect Immun. 2001 May;69(5):3442-6
references.pmid: 11292772
references.citation: Appl Environ Microbiol. 1983 Mar;45(3):1025-33
references.pmid: 6847178
references.citation: Trends Microbiol. 2001 Jan;9(1):34-9
references.pmid: 11166241
references.citation: Nat Rev Microbiol. 2008 Aug;6(8):635-43
references.pmid: 18536728
references.citation: BMC Evol Biol. 2013 Jan 28;13:22
references.pmid: 23356665
references.citation: Nature. 2009 Apr 30;458(7242):1176-9
references.pmid: 19252482
references.citation: Annu Rev Med. 2008;59:415-28
references.pmid: 17937586
references.citation: Nature. 2010 Oct 7;467(7316):711-3
references.pmid: 20844489
references.citation: Mol Microbiol. 2001 Jun;40(5):1187-99
references.pmid: 11401722
references.citation: Mol Microbiol. 2003 Dec;50(5):1683-701
references.pmid: 14651647
references.citation: PLoS One. 2012;7(12):e50527
references.pmid: 23236376
references.citation: FEMS Microbiol Rev. 2010 Mar;34(2):134-49
references.pmid: 20030732
references.citation: J Biol Chem. 2007 Nov 16;282(46):33275-33283
references.pmid: 17827157
references.citation: FEMS Microbiol Rev. 2012 May;36(3):616-48
references.pmid: 22404313
references.citation: J Bacteriol. 2007 Oct;189(20):7174-80
references.pmid: 17693508
references.citation: ACS Chem Biol. 2012 Aug 17;7(8):1420-8
references.pmid: 22620974
references.citation: Curr Opin Genet Dev. 1996 Oct;6(5):531-7
references.pmid: 8939730
references.citation: Environ Microbiol. 2008 Sep;10(9):2331-43
references.pmid: 18485000
references.citation: Clin Microbiol Infect. 2012 Dec;18 Suppl 6:21-7
references.pmid: 23121551
references.citation: Mol Microbiol. 2007 Oct;66(2):395-409
references.pmid: 17850253
references.citation: Infect Immun. 2012 Aug;80(8):2704-11
references.pmid: 22615253
references.citation: Nature. 2005 Aug 25;436(7054):1171-5
references.pmid: 16121184
references.citation: J Intern Med. 2012 Dec;272(6):541-61
references.pmid: 23025745
references.citation: Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):330-9
references.pmid: 21502971
references.citation: Mol Microbiol. 2009 Jun;72(6):1500-16
references.pmid: 19460094
references.citation: Microbiol Mol Biol Rev. 2000 Dec;64(4):847-67
references.pmid: 11104821
references.citation: Curr Top Microbiol Immunol. 2008;322:249-89
references.pmid: 18453280
references.citation: Infect Immun. 2002 Oct;70(10):5770-8
references.pmid: 12228307
references.citation: Antimicrob Agents Chemother. 2011 Aug;55(8):3691-5
references.pmid: 21646481
references.citation: Antimicrob Agents Chemother. 2012 Nov;56(11):6019-20
references.pmid: 22908175
references.citation: Curr Issues Intest Microbiol. 2002 Sep;3(2):23-7
references.pmid: 12400635
references.citation: J Bacteriol. 2013 Feb;195(3):545-55
references.pmid: 23175653
references.citation: Infect Immun. 2009 Sep;77(9):3661-9
references.pmid: 19564382
references.citation: J Med Microbiol. 2005 Feb;54(Pt 2):119-127
references.pmid: 15673504
references.citation: Science. 1999 May 21;284(5418):1318-22
references.pmid: 10334980
references.citation: Infect Immun. 2001 Apr;69(4):2144-53
references.pmid: 11254569
references.citation: Mol Microbiol. 2001 Jan;39(2):223-35
references.pmid: 11136445
references.citation: BMC Microbiol. 2006 Jun 12;6:53
references.pmid: 16768798
references.citation: FEMS Immunol Med Microbiol. 2012 Jul;65(2):318-25
references.pmid: 22444687
references.citation: Curr Top Microbiol Immunol. 2008;322:107-31
references.pmid: 18453274
references.citation: Nat Rev Microbiol. 2013 Mar;11(3):157-68
references.pmid: 23353768
references.citation: J Bacteriol. 2010 Aug;192(15):3969-76
references.pmid: 20511507